Champions Oncology Inc :Profits of 1 cents per share anticipated for third quarter

Champions Oncology

10/09/2021 21:11

10 September 202108:11 p.m. All figures in US dollars. 
Champions Oncology Inc is expected to show no change in
its third quarter earnings to  1 cents​ per share according to
the single analyst providing an estimate for the quarter. ​  
 
RECOMMENDATIONS 
* The consensus recommendation for the company is "Buy". This
includes three "Buy". 
* The average consensus recommendation for the biotechnology &
medical research peer group is also "Buy". 
 
FORECAST CHANGES
* Two analysts are currently providing Refinitiv with
estimates. 
* In the last week there have been no earnings estimate
revisions by analysts covering the company. There were no
changes to the number of estimates.
* In the last four weeks the earnings per share estimate   is
unchanged  from 1 cents.  .  There has been no changes to the
number of estimates.
* The StarMine predicted earnings surprise is too low to be
considered statistically significant. Predicted revenue surprise
is too low to be significant.
* The average price target from the two analysts providing
estimates is $15.67.
 
YEAR OVER YEAR
* The company is expected to report a rise in revenue to $10.98
million from $9.55 million in the same quarter last year.
* The current quarter consensus estimate of  1 cents per share  
implies no change from the same quarter last year when the
company reported 1 cents per share.
* Previous quarterly performance (using preferred earnings
measure)
 QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2021      0.26           0.29           Beat
 Mar. 31 2021      0.27           0.29           Beat
 Dec. 31  2020     0.31           0.35           Beat
 Sep. 30 2020      0.32           0.41           Beat
 
This summary was machine generated from Refinitiv data September
10 at 08:11 p.m